1/49
Looks like no tags are added yet.
pharmacotherapy
to obtain therapeutic effect without (minimal) side effects for a desired duration
pharmacokinetics
study and mathematical characterization of the time course of drug absorption, distribution, metabolism, and excretion processes that determine the time course of drug conc
pharmacodynamics
quantitative analysis of the intensity and time course of pharmacological effects based on the mechanism of action of the drug and concentration effect relationships
successful pharmacotherapy
understanding and controlling of both PK and PD of drug is essential
in vitro
technique of performing a given procedure in a controlled environment outside of a living organism
within the glass
in vitro
in vivo
experimentation using a whole, living organism as opposed to a partial or dead organism. animal studies and clinical trials
within the living
in vivo
in silico
preformed on computer or via computer simulation
in vitro drug conc
drug dose/ volume of media
in vivo drug conc at the target
F (dose, ADME)
to bind to receptors in the site of action, sufficient drug conc should reach the targets from the site of administration
drug exposure
measure as time dependent plasma concentration curve
plasma
used as a surrogate because difficult to collect tissues of disease in clinical settings/trials. drug is equilibrated ibetween plasma and target tissue
first pass effect
drug metabolism where the conc of drug is greatly reduced before it reaches the systemic circulation
effective drugs
reach the site of action (absorbed and distributed) and interact with their targets for enough time
barriers and targets
anatomical barriers, chemical barriers, biochemical barriers and targets
anatomical barriers
membranes
chemical barriers
body fluid, ph, solubility and ionization
biochemical barriers and targets
transporters, enzymes, and receptors
dissolution
rate limiting step in absorption of some oral solid dosage forms
2 different formulations
2 different dissolution rates, 2 different onset times and duration of actions
function of log C
relationship with pharmacological activity produces a sigmoidal curve pattern
drug plasma conc
driving force for drug activity/response, response is dependent on conc, time course of response depends on time course of conc
MSC
maximum safe conc
MEC
minimum effective conc
time course
after multiple dosing it can be simulated based on after single dosing, IV and PO dive two distinct patterns
time course parameters
Vd, CL, F, Co, Cmax, AUC, Tmax
Vd
volume of distribution
CL
clearance
A
absorption
F
fraction absorbed (bioavailability
dose and frequency
can be determined from half life and bioavailability
bioavailability (F)
fraction of initial dose that reaches the circulation after the first-pass effect (secondary dependent parameter)
F equation
=AUC oral/ AUC iv
volume of distribution
proportionality constant that relates the amount of drug in the body (A) with the measured plasma concentration
volume that would be necessary to contain the total amount of an administered drug at the same concentration that it is observed in the blood plasma
Vd usage
determines how readily the drug will displace into the body tissue compartments relative to the blood
higher Vd
greater amount of tissue distribution
typically drugs with high lipid solubility, low rates of ionization, weak basic groups, or low plasma protein binding capabilities
clearance
volume of plasma from which drug is totally remoced over a specific period of time
major clearing routes
metabolic, renal, biliary
total drug clearance
additive, equal to the sum of all clearance routes
methods of PK modeling
compartment models, PBPK (physiologically based PK models)
compartment models
simulate ADE
flow= rate constant K
compartment= group of tissue with a similar blood flow and affinity for the drug
PBPK
a kind of compartment model but each compartment represents an actual tissue and an organ space
flow=real blood flow Q
compartment=real tissue
occupancy theory
apply law of mass action to the relationship between concentration and target occupancy
receptor occupancy theory
assumed response is directly proportional to occupancy
hill equation
reflects the law of mass action, useful in quantitative pharmacology
limited conc/capacity of receptors or limitations in physiological systems produce nonlinear concentration vs response profiles
DMPK liabilities
low potency/selectivity
poor solubility
low Papp, high ER
low oral bioavailability
high clearance
low metabolic stability
CYP inhibition
DMPK
examine how the body handles a drug and help select better drug candidates early in development, identify potential issues early to improve safety and effectiveness
DMPK goals
optimize drug properties- absorption, bioavailability, clearance, half life, metabolic stability, protein binding
minimize potential problems- drug interactions, enzyme induction/inhibition, first pass metabolism, differences in metabolism bc of genetics
lead optimization through structure modification
improve potency and selectivity, achieve desired ADMET properties based on SAR and SPR analysis